Combination Therapy of Gefitinib and Korean Herbal Medicines Could be a Beneficial Option for Patients with Non-Small-Cell Lung Cancer
- Kangwook Lee
- Yoon-sik Kim
- Chang-Gue Son
- Jung-Hyo Cho
- Hwa-Seung Yoo
- Jonghoon Lee
- Juyoung Ryu
- Namhun Lee
Publication date
September 2016
DOI Publisher
Korean Pharmacopuncture Institute ISSN
2093-6966 Journal
issn:2234-6856Abstract
Abstract Abstract Lung cancer has a high mortality rate and is often diagnosed at the metastatic stage. Gefitinib is a targeted molecular therapeutic drug used to treat patients with non-small-cell lung cancer (NSCLC). Korean herbal medicines may also have therapeutic efficacy against lung cancer, reduce the side effects associated with c
Add to ORKG